2/253/3494090365 |
您所在的位置:网站首页 › 2/253/3494090365 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/37925144Clinical Response and Remission in Patients With Severe …网页Anti-Asthmatic Agents. Biological Products. Clinical response was achieved in most adult patients initiating biologic therapy, and clinical remission was observed in 19% of the patients following 12 months of treatment. Further studies are required to assess the long-term outcome of achieving clinical remission with biologic therapy.
发布时间:2024-07-12data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/30649942Two Paths to Health in All Policies: The Traditional Public网页2019 Feb;109(2):253-254. doi: 10.2105/AJPH.2018.304884. Author Robert A Hahn 1 Affiliation 1 Robert A. Hahn is with the Department of Anthropology, Emory University, Atlanta, GA. PMID: 30649942 PMCID: PMC6336061 DOI: 10.2105/AJPH.2018.304884 No abstract available ...
发布时间:2024-07-12data-id="" iid="">182.92.200.144http://182.92.200.144/CN/abstract/abstract860.shtml有氧糖酵解治疗靶点及其靶向药物的研究进展网页2021年12月16日 · 但是, 有氧糖酵解靶向治疗目前也存在两个困境:①肿瘤细胞本身的代谢异质性;②免疫系统在靶向糖酵解治疗过程中也会受到损伤。. 本文就有氧糖酵解的各个靶点及其靶向药物在肿瘤治疗中的研究进展及其靶向治疗目前存在的困境展开综述。. Abstract:Aerobic ...
发布时间:2024-07-12data-id="" iid="">2.139.253.142http://2.139.253.142:120032.139.253.142:12003网页由于此网站的设置,我们无法提供该页面的具体描述。
发布时间:2024-07-12CopyRight 2018-2019 实验室设备网 版权所有 |